Global Electrostatic Live Cell Encapsulation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Electrostatic Live Cell Encapsulation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Live cell encapsulation has long been proposed as a solution to many therapeutic problems in modern medicine. Cell encapsulation technology is used to immobilise cells within biocompatible and semipermeable membranes. Encapsulation of cells, rather than therapeutic products, is used to allow the delivery of molecules of interest for a longer time period because cells release these molecules of interest continuously. Furthermore, cells can be engineered to express the desired protein in vivo without modifying the host's genome. Cell encapsulation has a significant advantage over protein encapsulation because it allows for the sustained and controlled delivery of therapeutic molecules at a constant rate, resulting in higher physiological concentrations.
Electrostatic Live Cell Encapsulation report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Electrostatic Live Cell Encapsulation market is projected to reach US$ 395.5 million in 2033, increasing from US$ 297 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2033. Demand from Pharmacy and Regenerative Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Electrostatic Live Cell Encapsulation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Electrostatic Live Cell Encapsulation key companies include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, BÜCHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. ViaCyte, MIKROCAPS, Balchem Inc are top 3 players and held % share in total in 2022.
Electrostatic Live Cell Encapsulation can be divided into Alginate, HEMA-MMA, Chitosan and Siliceous Encapsulates, etc. Alginate is the mainstream product in the market, accounting for % share globally in 2022.
Electrostatic Live Cell Encapsulation is widely used in various fields, such as Pharmacy, Regenerative Medicine, Cell Transplantation and Other, etc. Pharmacy provides greatest supports to the Electrostatic Live Cell Encapsulation industry development. In 2022, global % share of Electrostatic Live Cell Encapsulation went into Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
BÜCHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Electrostatic Live Cell Encapsulation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Electrostatic Live Cell Encapsulation introduction, etc. Electrostatic Live Cell Encapsulation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Electrostatic Live Cell Encapsulation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electrostatic Live Cell Encapsulation report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Electrostatic Live Cell Encapsulation market is projected to reach US$ 395.5 million in 2033, increasing from US$ 297 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2033. Demand from Pharmacy and Regenerative Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Electrostatic Live Cell Encapsulation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Electrostatic Live Cell Encapsulation key companies include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, BÜCHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. ViaCyte, MIKROCAPS, Balchem Inc are top 3 players and held % share in total in 2022.
Electrostatic Live Cell Encapsulation can be divided into Alginate, HEMA-MMA, Chitosan and Siliceous Encapsulates, etc. Alginate is the mainstream product in the market, accounting for % share globally in 2022.
Electrostatic Live Cell Encapsulation is widely used in various fields, such as Pharmacy, Regenerative Medicine, Cell Transplantation and Other, etc. Pharmacy provides greatest supports to the Electrostatic Live Cell Encapsulation industry development. In 2022, global % share of Electrostatic Live Cell Encapsulation went into Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
BÜCHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Segment by Application
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Electrostatic Live Cell Encapsulation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Electrostatic Live Cell Encapsulation introduction, etc. Electrostatic Live Cell Encapsulation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Electrostatic Live Cell Encapsulation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices